Galderma Launches Sculptra in China
The launch follows regulatory approval and study results supporting Sculptra’s long-lasting correction of midface volume and contour loss.
The launch follows regulatory approval and study results supporting Sculptra’s long-lasting correction of midface volume and contour loss.
Autologous Spray-On Skin Cells are expanding what's possible in reconstructive surgery. By reducing donor skin requirements and supporting faster, more natural healing, the technology is helping surgeons improve both functional and aesthetic outcomes while reshaping the approach to burns, traumatic wounds, and complex reconstruction.